Healthcare provider profile · identity verified

Joseph Michael Schwinghamer

Family Practice · ELY, MN · NPI 1457458531

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	877	226
Amlodipine Besylate	Amlodipine Besylate	624	164
Losartan Potassium	Losartan Potassium	624	157
Hydrochlorothiazide	Hydrochlorothiazide	317	78
Metoprolol Succinate	Metoprolol Succinate	298	73
Lisinopril	Lisinopril	292	77
Omeprazole	Omeprazole	281	80
Levothyroxine Sodium	Levothyroxine Sodium	258	54
Metformin Hcl Er	Metformin Hcl	252	58
Gabapentin	Gabapentin	210	55
Sertraline Hcl	Sertraline Hcl	190	46
Tamsulosin Hcl	Tamsulosin Hcl	185	50
Eliquis	Apixaban	184	33
Potassium Chloride	Potassium Chloride	184	50
Rosuvastatin Calcium	Rosuvastatin Calcium	174	42
Carvedilol	Carvedilol	160	46
Furosemide	Furosemide	152	45
Duloxetine Hcl	Duloxetine Hcl	130	31
Metoprolol Tartrate	Metoprolol Tartrate	111	32
Prednisone	Prednisone	110	46
Allopurinol	Allopurinol	109	29
Pravastatin Sodium	Pravastatin Sodium	106	30
Metformin Hcl	Metformin Hcl	90	26
Simvastatin	Simvastatin	90	19
Tramadol Hcl	Tramadol Hcl	90	28
Ozempic	Semaglutide	84	13
Pioglitazone Hcl	Pioglitazone Hcl	84	21
Warfarin Sodium	Warfarin Sodium	77	20
Spironolactone	Spironolactone	74	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	72	14
Torsemide	Torsemide	70	16
Trazodone Hcl	Trazodone Hcl	70	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	12
Alendronate Sodium	Alendronate Sodium	68	14
Famotidine	Famotidine	68	17
Ezetimibe	Ezetimibe	64	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	14
Triamcinolone Acetonide	Triamcinolone Acetonide	54	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	15
Fluticasone Propionate	Fluticasone Propionate	50	21
Jantoven	Warfarin Sodium	49	17
Pantoprazole Sodium	Pantoprazole Sodium	48	13
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Mirtazapine	Mirtazapine	45	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	44	15
Levetiracetam	Levetiracetam	43	suppressed
Citalopram Hbr	Citalopram Hydrobromide	40	11
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	39	39
Tolterodine Tartrate Er	Tolterodine Tartrate	39	suppressed
Finasteride	Finasteride	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	36	17
Cephalexin	Cephalexin	36	32
Jardiance	Empagliflozin	34	suppressed
Victoza 3-Pak	Liraglutide	34	suppressed
Montelukast Sodium	Montelukast Sodium	33	suppressed
Clonazepam	Clonazepam	32	suppressed
Clopidogrel	Clopidogrel Bisulfate	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Xarelto	Rivaroxaban	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Ibuprofen	Ibuprofen	28	14
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Azithromycin	Azithromycin	26	24
Colchicine	Colchicine	26	suppressed
Sucralfate	Sucralfate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Nystatin	Nystatin	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Irbesartan	Irbesartan	23	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Lorazepam	Lorazepam	22	suppressed
Primidone	Primidone	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Glimepiride	Glimepiride	20	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	19	11
Nitroglycerin	Nitroglycerin	19	16
Baclofen	Baclofen	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	17
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Digoxin	Digoxin	18	suppressed
Dulera	Mometasone/Formoterol	18	suppressed
Glipizide	Glipizide	18	suppressed
Risperidone	Risperidone	18	suppressed
Sulfasalazine	Sulfasalazine	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Unifine Pentips	Pen Needle, Diabetic	17	suppressed
Buprenorphine	Buprenorphine	16	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Methenamine Hippurate	Methenamine Hippurate	15	suppressed
Nabumetone	Nabumetone	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	14
Atenolol	Atenolol	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Roflumilast	Roflumilast	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	12
Synthroid	Levothyroxine Sodium	14	suppressed
Bydureon Bcise	Exenatide Microspheres	13	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ibu	Ibuprofen	12	suppressed
Nifedipine Er	Nifedipine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Doxepin Hcl	Doxepin Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error